The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia

Schmitz, 1996, Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients, Lancet, 347, 353, 10.1016/S0140-6736(96)90536-X To, 1992, Comparison of heamatological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants, Bone Marrow Transplant, 9, 277 Roberts, 1993, Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation, Bone Marrow Transplant, 12, 469 Nademanee, 1995, The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate and prednisone, Blood, 86, 1228, 10.1182/blood.V86.3.1228.1228 Nash, 1996, FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors, Blood, 88, 3634, 10.1182/blood.V88.9.3634.bloodjournal8893634 Anasetti, 1995, Marrow transplantation from unrelated volunteer donors, Annu Rev Med, 46, 169, 10.1146/annurev.med.46.1.169 Goodrich, 1991, Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation, N Eng J Med, 325, 1601, 10.1056/NEJM199112053252303 Schmidt, 1991, A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bond marrow transplantation, N Eng J Med, 324, 1005, 10.1056/NEJM199104113241501 Rooney, 1995, Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation, Lancet, 345, 9, 10.1016/S0140-6736(95)91150-2 Heslop, 1996, Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes, Nat Med, 2, 551, 10.1038/nm0596-551 Handgretinger, 2001, Megadose transplantation of purified peripheral blood CD 34(+) progenitor cells from HLA-mismatched parental donors in children, Bone Marrow Transplant, 27, 777, 10.1038/sj.bmt.1702996 Anderlini, 2001, Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) database, Bone Marrow Transplant, 27, 689, 10.1038/sj.bmt.1702875 Körbling, 2001, Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?, Blood, 98, 2900, 10.1182/blood.V98.10.2900 Barker, 2002, Umbilical cord blood transplantation: current state of the art, Curr Opin Oncol, 14, 160, 10.1097/00001622-200203000-00004 Gluckman, 2000, Umbilical cord blood transplant, Curr Opin Hematol, 7, 353, 10.1097/00062752-200011000-00006 Couban, 1998, Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective, Bone Marrow Transplant, 22, 1199, 10.1038/sj.bmt.1701504 Bennett, 1999, Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation, Bone Marrow Transplant, 24, 555, 10.1038/sj.bmt.1701945 van Agthoven, 2002, Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantations in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia, Bone Marrow Transplant, 30, 243, 10.1038/sj.bmt.1703641 Majhail, 2009, Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttranplantation complications, Biol Blood Marrow Transplant, 15, 564, 10.1016/j.bbmt.2009.01.011 Costa, 2007, The cost-effectiveness of stem cell transplantations from unrelated donors in adult patients with acute leukemia, Value Health, 10, 247, 10.1111/j.1524-4733.2007.00180.x Hongeng, 1997, Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukemia, Lancet, 350, 767, 10.1016/S0140-6736(97)03098-5 Glucksberg, 1974, Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors, Transplantation, 18, 295, 10.1097/00007890-197410000-00001 Bureau of Labor Statistics. The Consumer Price Index (CPI), 2008. Available from: http://www.bls.gov/cpi/. Accessed January 12, 2009. Weisberg, 2005, Outliers and influence Mooney, 1993, Conclusion Critchfield, 1986, Probability sensitivity analysis methods for general decision models, Comput Biomed Res, 19, 254, 10.1016/0010-4809(86)90020-0 Doubilet, 1985, Probability sensitivity analysis using Monte Carlo simulation: a practical approach, Med Decis Making, 5, 157, 10.1177/0272989X8500500205 Manning, 1996, Reflecting uncertainty in cost-effectiveness analysis Lee, 1998, The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia, Blood, 92, 4047, 10.1182/blood.V92.11.4047 Uyl-de Groot, 1995, Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL), Bone Marrow Transplant, 16, 463 Welch, 1989, Cost-effectiveness of bone marrow transplantation in acute non-lymphocytic leukemia, N Eng J Med, 321, 807, 10.1056/NEJM198909213211207 Messori, 1997, Cost-effectiveness of autologous bone marrow transplantation in patients with relapsed non-Hodgkin's lymphoma, Bone Marrow Transplant, 19, 275, 10.1038/sj.bmt.1700642 Barr, 1996, Economic evaluation of allogeneic bone marrow transplantation: a rudimentary model to generate estimates for the timely formulation of clinical policy, J Clin Oncol, 14, 1413, 10.1200/JCO.1996.14.5.1413 Beard, 1991, The costs and benefits of bone marrow transplantation, N Z Med J, 104, 303 Kouroukis, 2003, Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma, Leuk Lymphoma, 44, 29, 10.3109/10428190309178811 Madero, 2000, Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children, Bone Marrow Transplant, 26, 269, 10.1038/sj.bmt.1702516